Actinium Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or adoptive cell therapies.
Actinium Pharmaceuticals stock last closed at $0.98, down 2.5% from the previous day, and has decreased 37.5% in one year. It has overperformed other stocks in the Biotechnology industry by 0.34 percentage points. Actinium Pharmaceuticals stock is currently +32.65% from its 52-week low of $0.74, and -43.97% from its 52-week high of $1.74.
As of Oct 14, 2026, there are 31.44M shares of ATNM outstanding. The market capitalization of ATNM is $30.66M. In the past 24 hours, 84,500 ATNM shares were traded.
You will need a brokerage account in order to access the NYSEMKT market and buy ATNM stock.
We believe that eToro is the best stock brokerage. eToro gives you:
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, it's time to fill out some personal details so you are able to invest in ATNM stock today.
Now that you have finished signing up on stock market apps, you need to deposit funds:
Check out the walkthrough below for more details depositing money into your new investment account.
Once you have identified the best place to buy Actinium Pharmaceuticals stock, it's crucial to research their stock before you invest, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on ATNM's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ATNM's fair value.
Using relative valuations metrics:
You can access additional valuation analysis on ATNM's stock here.
You can dig deeper into what analysts are forecasting on the Actinium Pharmaceuticals stock forecast page.
Last year, ATNM revenue was $35.09M. In the last five year, ATNM's revenue has gone up by 108.62% per year. This was faster than the Biotechnology industry average of 32.9%.
You can research ATNM's earnings and revenue performance here.
Over the last year, executives and large shareholders at ATNM have not bought or sold any shares.
Dig into more about who owns ATNM stock here.
No, Actinium Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
There are two primary order types:
Click the Open Trade button and your broker will execute the order.
If you need more info about investing in stocks on eToro, watch the how to video below:
Now that you own some shares in ATNM, you'll want to stay up-to-date on your new stock purchase.
Create a watchlist to get the latest updates about your ATNM stock.
To reiterate, here are the 6 steps to buy Actinium Pharmaceuticals stock:
If you require a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Actinium Pharmaceuticals, click below.